{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:14:44Z","timestamp":1788956084859,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["169084"],"award-info":[{"award-number":["169084"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012456","name":"Toronto General and Western Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012456","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002784","name":"Canada Excellence Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000014","name":"Canadian Blood Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010785","name":"Canada First Research Excellence Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.celrep.2024.115102","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T15:36:23Z","timestamp":1735054583000},"page":"115102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cell therapy with human IL-10-producing ILC2s limits xenogeneic graft-versus-host disease by inhibiting pathogenic T\u00a0cell responses"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4339-9317","authenticated-orcid":false,"given":"Kyle T.","family":"Reid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5657-8165","authenticated-orcid":false,"given":"Sarah J.","family":"Colpitts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2926-8222","authenticated-orcid":false,"given":"Jessica A.","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Santos Carreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0617-1666","authenticated-orcid":false,"given":"Julia M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6775-6641","authenticated-orcid":false,"given":"Dorota T.","family":"Borovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinthuja","family":"Jegatheeswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4171-4678","authenticated-orcid":false,"given":"Tommy","family":"Alfaro Moya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Sachewsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2673-0485","authenticated-orcid":false,"given":"Arthur","family":"Mortha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4744-6021","authenticated-orcid":false,"given":"Jong Bok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4649-0757","authenticated-orcid":false,"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Novitzky-Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5117-7453","authenticated-orcid":false,"given":"Sarah Q.","family":"Crome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2024.115102_bib1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.cell.2017.02.021","article-title":"Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation","volume":"168","author":"Lim","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115102_bib2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41577-022-00704-5","article-title":"Heterogeneity of type 2 innate lymphoid cells","volume":"22","author":"Spits","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/imm.12098","article-title":"Tissue-specific effector functions of innate lymphoid cells","volume":"139","author":"Bj\u00f6rkstr\u00f6m","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.celrep.2024.115102_bib4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate Lymphoid Cells: 10 Years On","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115102_bib5","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.4049\/jimmunol.2100661","article-title":"Searching for the Elusive Regulatory Innate Lymphoid Cell","volume":"207","author":"Jegatheeswaran","year":"2021","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib6","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.4373","article-title":"Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells","volume":"23","author":"Rauber","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2024.115102_bib7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaci.2014.06.024","article-title":"Enhanced innate type 2 immune response in peripheral blood from patients with asthma","volume":"134","author":"Bartemes","year":"2014","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2147\/JAA.S304126","article-title":"Healthy and Patient Type 2 Innate Lymphoid Cells are Differently Affected by in\u00a0vitro Culture Conditions","volume":"14","author":"Falquet","year":"2021","journal-title":"J.\u00a0Asthma Allergy"},{"key":"10.1016\/j.celrep.2024.115102_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02023-z","article-title":"Alternative activation generates IL-10 producing type 2 innate lymphoid cells","volume":"8","author":"Seehus","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115102_bib10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jaci.2020.08.024","article-title":"IL-10 production by ILC2s requires Blimp-1 and cMaf, modulates cellular metabolism, and ameliorates airway hyperreactivity","volume":"147","author":"Howard","year":"2021","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib11","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191520","article-title":"ILC2s are the predominant source of intestinal ILC-derived IL-10","volume":"217","author":"Bando","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2024.115102_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.immuni.2020.12.013","article-title":"Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response","volume":"54","author":"Golebski","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.115102_bib13","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.3414004","article-title":"Meningeal Type-2 Innate Lymphoid Cells Emerge as Novel Regulators of Microglial Activation and Blood-Brain Barrier Stability: A Central Role for IL-10","author":"Derecki","year":"2019","journal-title":"SSRN"},{"key":"10.1016\/j.celrep.2024.115102_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaci.2021.04.029","article-title":"Targeting androgen signaling in ILC2s protects from IL-33\u2013driven lung inflammation, independently of KLRG1","volume":"149","author":"Blanquart","year":"2022","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib15","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1084\/jem.20161653","article-title":"PD-1 regulates KLRG1+ group 2 innate lymphoid cells","volume":"214","author":"Taylor","year":"2017","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2024.115102_bib16","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.immuni.2020.02.009","article-title":"Interleukin-33 Induces the Enzyme Tryptophan Hydroxylase 1 to Promote Inflammatory Group 2 Innate Lymphoid Cell-Mediated Immunity","volume":"52","author":"Flamar","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.115102_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ni.3078","article-title":"IL-25-responsive, lineage-negative KLRG1hi cells are multipotential \u2018inflammatory\u2019 type 2 innate lymphoid cells","volume":"16","author":"Huang","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/2040620713489842","article-title":"Treatment and management of graft-versus-host disease: improving response and survival","volume":"4","author":"Garnett","year":"2013","journal-title":"Ther Adv Hematol."},{"key":"10.1016\/j.celrep.2024.115102_bib19","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/s41409-022-01764-w","article-title":"Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart review","volume":"57","author":"Holtan","year":"2022","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.celrep.2024.115102_bib20","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/s41409-022-01736-0","article-title":"Disease progression, hospital readmissions, and clinical outcomes for patients with steroid-refractory acute graft-versus-host disease: A multicenter, retrospective study","volume":"57","author":"Holtan","year":"2022","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.celrep.2024.115102_bib21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/bjh.16200","article-title":"Characteristics of graft-versus-host disease occurring after alemtuzumab-containing allogeneic stem cell transplants: incidence, organ involvement, risk factors and survival","volume":"188","author":"Finazzi","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.celrep.2024.115102_bib22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","article-title":"Risk factors for acute GVHD and survival after hematopoietic cell transplantation","volume":"119","author":"Jagasia","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.115102_bib23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.celrep.2024.115102_bib24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbmt.2011.06.012","article-title":"Steroid-Refractory Acute GVHD: Lack of Long-Term Improved Survival Using New Generation Anticytokine Treatment","volume":"18","author":"Xhaard","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.celrep.2024.115102_bib25","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1172\/JCI91816","article-title":"Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease","volume":"127","author":"Bruce","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2024.115102_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/JLB.5A1019-522RR","article-title":"Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation","volume":"111","author":"Piperoglou","year":"2022","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.celrep.2024.115102_bib27","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcyt.2021.10.011","article-title":"Presence of innate lymphoid cells in allogeneic hematopoietic grafts correlates with reduced graft-versus-host disease","volume":"24","author":"Kroeze","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.celrep.2024.115102_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00465","article-title":"Natural killer cells in graft-versus-host-disease after allogeneic hematopoietic cell transplantation","volume":"8","author":"Simonetta","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib29","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.bbmt.2016.09.006","article-title":"Early Natural Killer Cell Reconstitution Predicts Overall Survival in T Cell\u2013Replete Allogeneic Hematopoietic Stem Cell Transplantation","volume":"22","author":"Minculescu","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.celrep.2024.115102_bib30","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2013-11-536888","article-title":"Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease","volume":"124","author":"Munneke","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.115102_bib31","doi-asserted-by":"crossref","first-page":"eabf5264","DOI":"10.1126\/scitranslmed.abf5264","article-title":"Alloantigen-specific type 1 regulatory T\u00a0cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients","volume":"13","author":"Chen","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2024.115102_bib32","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nm.3179","article-title":"Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells","volume":"19","author":"Gagliani","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2024.115102_bib33","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.4049\/jimmunol.1800173","article-title":"Type 2 Innate Lymphoid Cells Impede IL-33-Mediated Tumor Suppression","volume":"201","author":"Long","year":"2018","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib34","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.4049\/jimmunol.0901247","article-title":"A2A Adenosine Receptor May Allow Expansion of T Cells Lacking Effector Functions in Extracellular Adenosine-Rich Microenvironments","volume":"183","author":"Ohta","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib35","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1182\/blood-2006-12-063982","article-title":"IFN\u03b3 differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract","volume":"110","author":"Burman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.115102_bib36","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1172\/JCI112474","article-title":"Gut injury in mouse graft-versus-host reaction. Study of its occurrence and mechanisms","volume":"77","author":"Guy-Grand","year":"1986","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2024.115102_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1236219","article-title":"Role of CD8 Regulatory T Cells versus Tc1 and Tc17 Cells in the Development of Human Graft-versus-Host Disease","volume":"2017","author":"Guti\u00e9rrez-Hoya","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.celrep.2024.115102_bib38","first-page":"1385","article-title":"IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease","volume":"58","author":"Szebeni","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.celrep.2024.115102_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01943","article-title":"Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2\/HHD Mice","volume":"9","author":"Ehx","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41434-022-00358-x","article-title":"Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T\u00a0cells for use in solid organ transplantation","volume":"30","author":"Proics","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.celrep.2024.115102_bib41","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/eji.200838908","article-title":"The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T\u00a0cells","volume":"39","author":"Crome","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib42","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.4049\/jimmunol.1000557","article-title":"Inflammatory Effects of Ex\u00a0Vivo Human Th17 Cells Are Suppressed by Regulatory T Cells","volume":"185","author":"Crome","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib43","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ni1467","article-title":"Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib44","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#","article-title":"CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2\u00a0T cytotoxic cells in health and disease","volume":"30","author":"Cosmi","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib45","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nri954","article-title":"The lineage decisions of helper T\u00a0cells","volume":"2","author":"Murphy","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib46","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/cmi.2015.50","article-title":"Interleukin-13 interferes with activation-induced t-cell apoptosis by repressing p53 expression","volume":"13","author":"Yang","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib47","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012305","article-title":"IL -10 producing type 2 innate lymphoid cells prolong islet\u00a0allograft survival","volume":"12","author":"Huang","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.celrep.2024.115102_bib48","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1182\/bloodadvances.2020001514","article-title":"Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHD","volume":"5","author":"Bruce","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.celrep.2024.115102_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.716606","article-title":"Augmented expansion of Treg cells from healthy and autoimmune subjects via adult progenitor cell Co-culture","volume":"12","author":"Reading","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123672","article-title":"Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T\u00a0cells","volume":"4","author":"Dawson","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.celrep.2024.115102_bib51","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.1631","article-title":"Immune Cell Isolation from Mouse Femur Bone Marrow","volume":"5","author":"Liu","year":"2015","journal-title":"Bio-protocol"},{"key":"10.1016\/j.celrep.2024.115102_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1107582","article-title":"Strategies for optimizing CITE-seq for human islets and other tissues","volume":"14","author":"Colpitts","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2024.115102_bib53","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115102_bib54","doi-asserted-by":"crossref","first-page":"861","DOI":"10.21105\/joss.00861","article-title":"UMAP: Uniform Manifold Approximation and Projection","volume":"3","author":"McInnes","year":"2018","journal-title":"J.\u00a0Open Source Softw."},{"key":"10.1016\/j.celrep.2024.115102_bib55","article-title":"EnhancedVolcano: publication-ready volcano plots with enhanced colouring and labeling","author":"Blighe","year":"2020","journal-title":"Bioconductor Release 3.20"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724014530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724014530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:26:52Z","timestamp":1781555212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124724014530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2211124724014530"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2024.115102","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.08.21.554158","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell therapy with human IL-10-producing ILC2s limits xenogeneic graft-versus-host disease by inhibiting pathogenic T\u00a0cell responses","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2024.115102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115102"}}